Cargando…

Midwives’ and Women’s Perception on Moyo Fetal Heart Rate Monitor for Intrapartum Fetal Heart Rate Monitoring; A Cross-Sectional Study

BACKGROUND: The annual global neonatal mortality stands at 2.5 million deaths, 1 million of them dying within the first day of life. An additional 2.6 million are stillborn globally, the majority of them due to intrapartum events. Optimal fetal heart rate (FHR) monitoring has the potential to timely...

Descripción completa

Detalles Bibliográficos
Autores principales: Mdoe, Paschal, Yeconia, Anita, Buu, Fanuel, Kusulla, Simeon, Blacy, Ladislaus, Guga, Godfrey, Mduma, Estomih, Kidanto, Hussein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092687/
https://www.ncbi.nlm.nih.gov/pubmed/32256129
http://dx.doi.org/10.2147/MDER.S241741
_version_ 1783510153676455936
author Mdoe, Paschal
Yeconia, Anita
Buu, Fanuel
Kusulla, Simeon
Blacy, Ladislaus
Guga, Godfrey
Mduma, Estomih
Kidanto, Hussein
author_facet Mdoe, Paschal
Yeconia, Anita
Buu, Fanuel
Kusulla, Simeon
Blacy, Ladislaus
Guga, Godfrey
Mduma, Estomih
Kidanto, Hussein
author_sort Mdoe, Paschal
collection PubMed
description BACKGROUND: The annual global neonatal mortality stands at 2.5 million deaths, 1 million of them dying within the first day of life. An additional 2.6 million are stillborn globally, the majority of them due to intrapartum events. Optimal fetal heart rate (FHR) monitoring has the potential to timely detect fetuses at risk and, if coupled with timely obstetric responses may save more newborns. Moyo is a new Doppler with nine crystals capable of monitoring FHR both intermittently and continuously. AIM: To assess women’s and midwives’ opinions on the use of Moyo for intrapartum FHR monitoring. METHODS: We conducted a cross-sectional study using a structured questionnaire to assess women’s and midwives’ perception. Women who gave birth at the hospital who used Moyo were interviewed using a questionnaire immediately before discharge from the hospital. Twenty-eight midwives who have been using Moyo for more than 6 months were also interviewed using a structured questionnaire. Data were analyzed using excel and result presented in figures. RESULTS: In total 113 postpartum women who were monitored using Moyo were interviewed before discharge. Out of these, 46 (40.7%) were first-time mothers and the rest were multipara. In total, 95 women (84.1%) used Moyo and other devices for FHR monitoring, 81 (72%) said Moyo was better than Fetoscopes and handheld Doppler, two-third 75 (66.4%) felt that Moyo was comfortable and 93 (82.3%) would like Moyo to be used on them in the future. Out of 28 midwives, 11 (39.3%) used Moyo continuous only, 3 (10.7%) used Moyo intermittently only and 14 (50.0%) used both intermittent and continuous. Thirteen (46.4%) midwives prefer to use Moyo both intermittent and continuous. Sixteen (55.6%) said Moyo was effective, 21 (75%) felt comfortable to use Moyo, and 13 (46.4%) said Moyo was easy to use. CONCLUSION: The majority of midwives and women who used Moyo felt that Moyo was comfortable for intrapartum FHR monitoring. Moyo can be used both intermittently and continuously depending on the user’s preferences.
format Online
Article
Text
id pubmed-7092687
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70926872020-04-01 Midwives’ and Women’s Perception on Moyo Fetal Heart Rate Monitor for Intrapartum Fetal Heart Rate Monitoring; A Cross-Sectional Study Mdoe, Paschal Yeconia, Anita Buu, Fanuel Kusulla, Simeon Blacy, Ladislaus Guga, Godfrey Mduma, Estomih Kidanto, Hussein Med Devices (Auckl) Original Research BACKGROUND: The annual global neonatal mortality stands at 2.5 million deaths, 1 million of them dying within the first day of life. An additional 2.6 million are stillborn globally, the majority of them due to intrapartum events. Optimal fetal heart rate (FHR) monitoring has the potential to timely detect fetuses at risk and, if coupled with timely obstetric responses may save more newborns. Moyo is a new Doppler with nine crystals capable of monitoring FHR both intermittently and continuously. AIM: To assess women’s and midwives’ opinions on the use of Moyo for intrapartum FHR monitoring. METHODS: We conducted a cross-sectional study using a structured questionnaire to assess women’s and midwives’ perception. Women who gave birth at the hospital who used Moyo were interviewed using a questionnaire immediately before discharge from the hospital. Twenty-eight midwives who have been using Moyo for more than 6 months were also interviewed using a structured questionnaire. Data were analyzed using excel and result presented in figures. RESULTS: In total 113 postpartum women who were monitored using Moyo were interviewed before discharge. Out of these, 46 (40.7%) were first-time mothers and the rest were multipara. In total, 95 women (84.1%) used Moyo and other devices for FHR monitoring, 81 (72%) said Moyo was better than Fetoscopes and handheld Doppler, two-third 75 (66.4%) felt that Moyo was comfortable and 93 (82.3%) would like Moyo to be used on them in the future. Out of 28 midwives, 11 (39.3%) used Moyo continuous only, 3 (10.7%) used Moyo intermittently only and 14 (50.0%) used both intermittent and continuous. Thirteen (46.4%) midwives prefer to use Moyo both intermittent and continuous. Sixteen (55.6%) said Moyo was effective, 21 (75%) felt comfortable to use Moyo, and 13 (46.4%) said Moyo was easy to use. CONCLUSION: The majority of midwives and women who used Moyo felt that Moyo was comfortable for intrapartum FHR monitoring. Moyo can be used both intermittently and continuously depending on the user’s preferences. Dove 2020-03-18 /pmc/articles/PMC7092687/ /pubmed/32256129 http://dx.doi.org/10.2147/MDER.S241741 Text en © 2020 Mdoe et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mdoe, Paschal
Yeconia, Anita
Buu, Fanuel
Kusulla, Simeon
Blacy, Ladislaus
Guga, Godfrey
Mduma, Estomih
Kidanto, Hussein
Midwives’ and Women’s Perception on Moyo Fetal Heart Rate Monitor for Intrapartum Fetal Heart Rate Monitoring; A Cross-Sectional Study
title Midwives’ and Women’s Perception on Moyo Fetal Heart Rate Monitor for Intrapartum Fetal Heart Rate Monitoring; A Cross-Sectional Study
title_full Midwives’ and Women’s Perception on Moyo Fetal Heart Rate Monitor for Intrapartum Fetal Heart Rate Monitoring; A Cross-Sectional Study
title_fullStr Midwives’ and Women’s Perception on Moyo Fetal Heart Rate Monitor for Intrapartum Fetal Heart Rate Monitoring; A Cross-Sectional Study
title_full_unstemmed Midwives’ and Women’s Perception on Moyo Fetal Heart Rate Monitor for Intrapartum Fetal Heart Rate Monitoring; A Cross-Sectional Study
title_short Midwives’ and Women’s Perception on Moyo Fetal Heart Rate Monitor for Intrapartum Fetal Heart Rate Monitoring; A Cross-Sectional Study
title_sort midwives’ and women’s perception on moyo fetal heart rate monitor for intrapartum fetal heart rate monitoring; a cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092687/
https://www.ncbi.nlm.nih.gov/pubmed/32256129
http://dx.doi.org/10.2147/MDER.S241741
work_keys_str_mv AT mdoepaschal midwivesandwomensperceptiononmoyofetalheartratemonitorforintrapartumfetalheartratemonitoringacrosssectionalstudy
AT yeconiaanita midwivesandwomensperceptiononmoyofetalheartratemonitorforintrapartumfetalheartratemonitoringacrosssectionalstudy
AT buufanuel midwivesandwomensperceptiononmoyofetalheartratemonitorforintrapartumfetalheartratemonitoringacrosssectionalstudy
AT kusullasimeon midwivesandwomensperceptiononmoyofetalheartratemonitorforintrapartumfetalheartratemonitoringacrosssectionalstudy
AT blacyladislaus midwivesandwomensperceptiononmoyofetalheartratemonitorforintrapartumfetalheartratemonitoringacrosssectionalstudy
AT gugagodfrey midwivesandwomensperceptiononmoyofetalheartratemonitorforintrapartumfetalheartratemonitoringacrosssectionalstudy
AT mdumaestomih midwivesandwomensperceptiononmoyofetalheartratemonitorforintrapartumfetalheartratemonitoringacrosssectionalstudy
AT kidantohussein midwivesandwomensperceptiononmoyofetalheartratemonitorforintrapartumfetalheartratemonitoringacrosssectionalstudy